http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009148394-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_213f9043dcd30be07b256a04ea2f41ba |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01M1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L9-12 |
filingDate | 2007-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_507833fbdbed757bb53eecda44dba703 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_973ba3d68e653828a50c2d2cd3f44f1e |
publicationDate | 2009-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2009148394-A |
titleOfInvention | Drug volatilizer |
abstract | Disclosed is a drug volatilizer that allows a user to determine the end of a volatile drug held in the main body of the drug volatilizer while having a simple configuration at low cost. A volatile drug 11 and a pigment 13 are held in a chemical volatilization body 10, and a volatilization port 12 for volatilizing the volatile chemical drug 11 is provided only on a part of the surface of the main body of the chemical volatilization body 10. Therefore, since the volatile agent 11 is continuously volatilized from the volatilization port 12, the volatile agent 11 moves toward the volatilization port as a whole due to its osmotic pressure, and at this time, the dye 13 also moves along with this movement. It will move to the evaporation port 12. And since the pigment | dye 13 is made non-volatile thru | or non-volatile, after the volatile chemical | medical agent 11 has volatilized, the pigment | dye 13 will concentrate and remain in the volatilization opening | mouth 12 vicinity, and a volatile chemical | medical agent will remain. The user can easily discriminate the volatilization state of the volatile drug 11 by visual recognition based on the last period of 11 and the change of the pattern of the pigment 13 with time. [Selection] Figure 1 |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106386766-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011040590-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012514701-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011072606-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011072608-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011072607-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011072609-A |
priorityDate | 2007-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 36.